FAM111A
Basic information
Region (hg38): 11:59142748-59155039
Links
Phenotypes
GenCC
Source:
- autosomal dominant Kenny-Caffey syndrome (Strong), mode of inheritance: AD
- autosomal dominant Kenny-Caffey syndrome (Definitive), mode of inheritance: AD
- autosomal dominant Kenny-Caffey syndrome (Moderate), mode of inheritance: AD
- osteocraniostenosis (Supportive), mode of inheritance: AD
- autosomal dominant Kenny-Caffey syndrome (Supportive), mode of inheritance: AD
- osteocraniostenosis (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Kenny-Caffey syndrome, type 2 | AD | Endocrine | Among other findings, individuals may manifest with primary hypoparathyroidism with hypocalcemia (which can be life-threatening), and awareness may allow early management | Craniofacial; Endocrine; Musculoskeletal; Ophthalmologic | 23684011 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAM111A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 48 | 10 | 59 | |||
missense | 104 | 16 | 19 | 143 | ||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 12 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 12 | |||||
Total | 0 | 5 | 119 | 76 | 35 |
Variants in FAM111A
This is a list of pathogenic ClinVar variants found in the FAM111A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-59148565-A-G | Benign (Nov 11, 2018) | |||
11-59148707-C-T | Likely benign (Sep 08, 2020) | |||
11-59148880-G-C | Uncertain significance (Oct 04, 2023) | |||
11-59148887-G-A | Likely benign (Mar 13, 2022) | |||
11-59148897-C-T | Uncertain significance (Aug 27, 2023) | |||
11-59148899-G-A | Likely benign (Apr 24, 2022) | |||
11-59148935-C-A | Uncertain significance (Jul 23, 2023) | |||
11-59148935-C-T | FAM111A-related disorder | Likely benign (Jan 29, 2024) | ||
11-59148936-G-A | Uncertain significance (Jan 18, 2024) | |||
11-59148952-C-T | Inborn genetic diseases | Conflicting classifications of pathogenicity (Apr 13, 2023) | ||
11-59148953-G-A | Uncertain significance (Aug 04, 2023) | |||
11-59149021-A-G | Benign (Nov 26, 2019) | |||
11-59149122-A-G | Benign (Nov 26, 2019) | |||
11-59149222-G-A | Likely benign (Nov 02, 2020) | |||
11-59149245-AT-A | Benign (Jan 28, 2020) | |||
11-59151621-A-T | Benign (Nov 26, 2019) | |||
11-59151738-AT-A | Likely benign (Oct 29, 2023) | |||
11-59151749-G-C | Uncertain significance (Nov 19, 2021) | |||
11-59151775-G-A | Benign (Jan 15, 2024) | |||
11-59151793-G-T | Uncertain significance (Nov 03, 2023) | |||
11-59151794-G-A | Likely benign (May 16, 2018) | |||
11-59151801-T-A | Inborn genetic diseases | Uncertain significance (Oct 13, 2023) | ||
11-59151801-T-C | Uncertain significance (May 20, 2023) | |||
11-59151834-C-G | Uncertain significance (Sep 06, 2023) | |||
11-59151835-A-G | Uncertain significance (Dec 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FAM111A | protein_coding | protein_coding | ENST00000528737 | 2 | 12292 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00222 | 0.327 | 125679 | 0 | 2 | 125681 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0210 | 324 | 323 | 1.00 | 0.0000161 | 4101 |
Missense in Polyphen | 75 | 76.872 | 0.97565 | 1050 | ||
Synonymous | 0.413 | 106 | 112 | 0.950 | 0.00000560 | 1093 |
Loss of Function | -1.21 | 3 | 1.43 | 2.09 | 6.01e-8 | 19 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000983 | 0.00000880 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Chromatin-associated protein required for PCNA loading on replication sites. Promotes S-phase entry and DNA synthesis (PubMed:24561620). May directly function at replication forks, explaining why Simian virus 40 (SV40) interacts with FAM111A to overcome host range restriction (PubMed:23093934). {ECO:0000269|PubMed:23093934, ECO:0000269|PubMed:24561620}.;
- Disease
- DISEASE: Kenny-Caffey syndrome 2 (KCS2) [MIM:127000]: A disorder characterized by impaired skeletal development with small and dense bones, short stature, and primary hypoparathyroidism with hypocalcemia. Clinical features include cortical thickening and medullary stenosis of the tubular bones, delayed closure of fontanels, defective dentition, small eyes with hypermetropia, and frontal bossing with a triangular face. {ECO:0000269|PubMed:23684011, ECO:0000269|PubMed:23996431, ECO:0000269|PubMed:24635597}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gracile bone dysplasia (GCLEB) [MIM:602361]: A perinatally lethal condition characterized by narrowing of the medullary cavity of the long bones and of the skull, gracile bones with thin diaphyses, premature closure of basal cranial sutures, and microphthalmia. Most affected individuals who survive beyond the perinatal period develop hypocalcemia with low parathyroid hormone levels. {ECO:0000269|PubMed:23684011}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.239
- rvis_EVS
- -0.26
- rvis_percentile_EVS
- 34.88
Haploinsufficiency Scores
- pHI
- 0.0784
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.000122
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fam111a
- Phenotype
Gene ontology
- Biological process
- DNA replication;viral process;negative regulation of viral genome replication;defense response to virus
- Cellular component
- chromatin;fibrillar center;nucleus;cytoplasm
- Molecular function
- protein binding